Paul J Maddon
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1996First federal award
$3.1MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 1, 2004 | NIH | SBIR/STTR Phase I CCR5 inhibitors that block HIV but not chemokines | $304K | PROGENICS PHARMACEUTICALS INC |
| Sep 1, 2001 | NIH | SBIR/STTR Phase II Development of Small-Molecule HIV Entry Inhibitors | $899K | PROGENICS PHARMACEUTICALS INC |
| Jul 1, 1998 | NIH | NIH R01 CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS | $546K | PROGENICS PHARMACEUTICALS INC |
| Jul 1, 1998 | NIH | NIH R01 CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS | $546K | PROGENICS PHARMACEUTICALS INC |
| Aug 14, 1996 | NIH | SBIR/STTR Phase II DEVELOPMENT OF ANTICO RECEPTOR MABS FOR HIV THERAPY | $813K | PROGENICS PHARMACEUTICALS INC |
Peer ranks
Federal funding#128
Awards as PI#156
Patents#27
Companies
- PROGENICS PHARMACEUTICALS INCLinked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.